Astena Holdings Co

Astena Holdings Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Astena Holdings Co (8095.T) as of Nov 12, 2026 is 0.16. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.30 — a change of -46.81% (lower).

PEG

0.16

YoY

-46.81%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Astena Holdings Co is 2025 0.16 . PEG Ratio (Price/Earnings-to-Growth) of Astena Holdings Co was 2024 0.30 . It decreases by -46.81% lower compared to the previous year.

The Astena Holdings Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2017
0.28 JPY
Jan 1, 2018
0.25 JPY
Jan 1, 2019
0.23 JPY
Jan 1, 2020
0.18 JPY
Jan 1, 2021
0.20 JPY
Jan 1, 2022
0.61 JPY
Jan 1, 2023
0.30 JPY
Jan 1, 2025
0.16 JPY
The Astena Holdings Co PEG history
YEARPEGYoY
0.16-46.81%
0.30-50.15%
0.61+199.68%
0.20+14.21%
0.18-22.70%
0.23-7.74%
0.25-12.22%
0.28-59.31%
0.70—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Astena Holdings Co Stock analysis

What does Astena Holdings Co do? Astena Holdings Co., Ltd. generates revenue through four business segments. The Fine Chemicals segment sells pharmaceutical raw materials and pharmaceuticals to manufacturers. The Medical segment produces and sells pharmaceutical products directly to healthcare providers. The HBC and Food segment offers cosmetic raw materials, functional food raw materials, general use medicines, and cosmetics to retailers and distributors. The Industrial Chemicals segment supplies electronic industry chemicals, surface treatment chemicals, and related products to manufacturing plants and printed circuit board producers. Consulting services form part of the other businesses segment, providing additional revenue streams. The company's products target pharmaceutical manufacturers, healthcare providers, retailers, distributors, and industrial manufacturing plants. These segments include pharmaceutical raw material suppliers, medical product distributors, cosmetic and food raw material buyers, and electronics industry chemical users. The firm's sales are driven by direct B2B transactions across these diverse industrial and consumer markets. Astena's revenue streams are diversified across pharmaceutical, medical, cosmetic, food, and industrial chemical markets. The Fine Chemicals and Medical segments focus on healthcare-related products, while HBC and Food serves both cosmetic and food industries. Industrial Chemicals caters to electronics manufacturing needs. Consulting services complement the core product lines, enhancing the company's market presence across multiple sectors. Astena Holdings Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Astena Holdings Co stock

PEG Ratio (Price/Earnings-to-Growth) of Astena Holdings Co is 0.16 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Astena Holdings Co changed from 0.30 to 0.16, representing a -46.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Astena Holdings Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Astena Holdings Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Astena Holdings Co

All Key Metrics — Astena Holdings Co